Outcomes and Adverse Events Among Patients with Vancomycin-Resistant Enterococcal Bloodstream Infection Treated with Daptomycin Doses Greater than 12 mg/kg

Abstract Introduction Daptomycin is commonly used for vancomycin-resistant enterococcal bloodstream infections (VRE-BSIs); however, its optimal dosing remains uncertain. Although doses > 12 mg/kg may improve attainment of pharmacodynamic targets, clinical outcomes and safety data for very-high–dose...

Description complète

Détails bibliographiques

Auteurs principaux:	Luo-Wei Lin, Yu-Chung Chuang, Jia-Ling Yang, Chi-Ying Lin, Sung-Hsi Huang, Jann-Tay Wang, Yee-Chun Chen, Shan-Chwen Chang
Format:	Artigo
Langue:	Inglês
Publié:	Adis, Springer Healthcare 2026-05-01
Collection:	Infectious Diseases and Therapy
Sujets:	Daptomycin Vancomycin-resistant enterococcus Bloodstream infection Creatine kinase Eosinophilic pneumonia
Accès en ligne:	https://doi.org/10.1007/s40121-026-01369-6
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!